Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04143126 · ClinicalTrials.gov registry record · NA

Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)

A NA study of Schizophrenia, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04143126 is a NA study of Schizophrenia that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 90 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04143126, a NA study of Schizophrenia, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This project will conduct a confirmatory efficacy trial of two novel psychosocial interventions, Cognitive Enhancement Therapy and Enriched Supportive Therapy, for the treatment of persistent negative symptoms in schizophrenia.

Conditions Studied

Schizophrenia

Interventions

  • BEHAVIORAL Cognitive Enhancement Therapy
  • BEHAVIORAL Enriched Supportive Therapy

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-10-01
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04143126

The ClinicalTrials.gov registry entry for NCT04143126 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (59% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Enhancement Therapy is the first listed.

NCT04143126 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04143126 about?

NCT04143126 is a clinical study titled "Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)". This project will conduct a confirmatory efficacy trial of two novel psychosocial interventions, Cognitive Enhancement Therapy and Enriched Supportive Therapy, for the treatment of persistent negative symptoms in schizophrenia.

What is the current status of trial NCT04143126?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2019-10-01. Estimated completion is 2026-06-30.

What conditions does trial NCT04143126 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT04143126?

The interventions under investigation include: Cognitive Enhancement Therapy (BEHAVIORAL), Enriched Supportive Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04143126?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04143126 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.